$592 Million is the total value of SECTOR GAMMA AS's 34 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 23.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BMY | Buy | BRISTOL MYERS SQUIBB CO | $70,321,000 | +14.7% | 1,386,722 | +2.6% | 11.88% | +20.6% |
| BAX | Buy | BAXTER INTL INC | $41,313,000 | +9.1% | 472,305 | +2.2% | 6.98% | +14.7% |
| GILD | Buy | GILEAD SCIENCES INC | $30,109,000 | +0.1% | 475,056 | +6.7% | 5.09% | +5.3% |
| INCY | Buy | INCYTE CORP | $25,676,000 | -3.7% | 345,893 | +10.2% | 4.34% | +1.2% |
| REGN | Buy | REGENERON PHARMACEUTICALS | $21,037,000 | +16.6% | 75,835 | +31.6% | 3.55% | +22.6% |
| ANTM | Buy | ANTHEM INC | $17,913,000 | -13.2% | 74,607 | +2.1% | 3.03% | -8.7% |
| LLY | New | LILLY ELI & CO | $17,010,000 | – | 152,105 | +100.0% | 2.87% | – |
| QGEN | Buy | QIAGEN NV | $15,977,000 | -7.0% | 484,601 | +14.4% | 2.70% | -2.2% |
| TAK | Buy | TAKEDA PHARMACEUTICAL CO LTDsponsored ads | $14,040,000 | -0.4% | 816,299 | +2.5% | 2.37% | +4.7% |
| BRKR | Buy | BRUKER CORP | $13,531,000 | +21.5% | 308,004 | +38.1% | 2.29% | +27.7% |
| UTHR | New | UNITED THERAPEUTICS CORP DEL | $11,815,000 | – | 148,147 | +100.0% | 2.00% | – |
| ELAN | Buy | ELANCO ANIMAL HEALTH INC | $11,089,000 | +77.3% | 417,042 | +125.4% | 1.87% | +86.5% |
| THC | Buy | TENET HEALTHCARE CORP | $9,504,000 | +40.0% | 429,677 | +30.7% | 1.61% | +47.2% |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $8,811,000 | – | 89,964 | +100.0% | 1.49% | – |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $7,793,000 | +49.4% | 96,900 | +34.8% | 1.32% | +57.0% |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $7,400,000 | +46.3% | 172,978 | +117.2% | 1.25% | +53.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-05
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.